283 related articles for article (PubMed ID: 8835896)
1. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients.
Veloso FT; Carvalho J; Magro F
J Clin Gastroenterol; 1996 Jul; 23(1):29-34. PubMed ID: 8835896
[TBL] [Abstract][Full Text] [Related]
2. Mucocutaneous manifestations in inflammatory bowel disease.
Yüksel I; Başar O; Ataseven H; Ertuğrul I; Arhan M; Ibiş M; Dağli U; Demirel BT; Ulker A; Seçilmiş S; Saşmaz N
Inflamm Bowel Dis; 2009 Apr; 15(4):546-50. PubMed ID: 19023896
[TBL] [Abstract][Full Text] [Related]
3. Mucocutaneous manifestations of inflammatory bowel disease in central China -a single-centre study.
Kou CX; Zhang YY; Li GW; Li J; Kong QT; Chen J; Liu F; Zhang M; Wang FY; Jiang Y; Hao LY; Ren JA; Sang H
J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):e211-e212. PubMed ID: 29194792
[No Abstract] [Full Text] [Related]
4. Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease.
Ampuero J; Rojas-Feria M; Castro-Fernández M; Cano C; Romero-Gómez M
J Gastroenterol Hepatol; 2014 Feb; 29(2):291-5. PubMed ID: 23927379
[TBL] [Abstract][Full Text] [Related]
5. Mucocutaneous manifestations of inflammatory bowel disease in Turkey.
Topaloğlu Demir F; Kocatürk E; Yorulmaz E; Adalı G; Kavala M
J Cutan Med Surg; 2014 Nov; 18(6):397-404. PubMed ID: 25348761
[TBL] [Abstract][Full Text] [Related]
6. Extraintestinal manifestations in inflammatory bowel disease: Prevalence and predictors in Indian patients.
Bandyopadhyay D; Bandyopadhyay S; Ghosh P; De A; Bhattacharya A; Dhali GK; Das K
Indian J Gastroenterol; 2015 Sep; 34(5):387-94. PubMed ID: 26614005
[TBL] [Abstract][Full Text] [Related]
7. Peripheral arthritis in the course of inflammatory bowel diseases.
Yüksel I; Ataseven H; Başar O; Köklü S; Ertuğrul I; Ulker A; Dağlı U; Saşmaz N
Dig Dis Sci; 2011 Jan; 56(1):183-7. PubMed ID: 20458624
[TBL] [Abstract][Full Text] [Related]
8. Extraintestinal Manifestations in Vedolizumab and Anti-TNF-Treated Patients With Inflammatory Bowel Disease.
Dubinsky MC; Cross RK; Sandborn WJ; Long M; Song X; Shi N; Ding Y; Eichner S; Pappalardo B; Ganguli A; Wang A
Inflamm Bowel Dis; 2018 Aug; 24(9):1876-1882. PubMed ID: 29668916
[TBL] [Abstract][Full Text] [Related]
9. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients.
Greenstein AJ; Janowitz HD; Sachar DB
Medicine (Baltimore); 1976 Sep; 55(5):401-12. PubMed ID: 957999
[TBL] [Abstract][Full Text] [Related]
10. [Cutaneous manifestations in inflammatory bowel disease].
Chavez-Álvarez S; Gómez-Flores M; Ocampo-Candiani J
Gac Med Mex; 2016; 152(5):622-630. PubMed ID: 27792697
[TBL] [Abstract][Full Text] [Related]
11. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
Kujundzić M
Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Kilic Y; Kamal S; Jaffar F; Sriranganathan D; Quraishi MN; Segal JP
Inflamm Bowel Dis; 2024 Feb; 30(2):230-239. PubMed ID: 37042969
[TBL] [Abstract][Full Text] [Related]
13. [Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn's disease and ulcerative colitis].
Mendoza JL; Lana R; Taxonera C; Alba C; Izquierdo S; Díaz-Rubio M
Med Clin (Barc); 2005 Sep; 125(8):297-300. PubMed ID: 16159555
[TBL] [Abstract][Full Text] [Related]
14. The effect of infliximab on extraintestinal manifestations of Crohn's disease.
Kaufman I; Caspi D; Yeshurun D; Dotan I; Yaron M; Elkayam O
Rheumatol Int; 2005 Aug; 25(6):406-10. PubMed ID: 15309501
[TBL] [Abstract][Full Text] [Related]
15. [Immune-mediated inflammatory diseases in patients with inflammatory bowel disease. Baseline data from the Aquiles study].
Marín-Jiménez I; García Sánchez V; Gisbert JP; Lázaro Pérez Calle J; Luján M; Gordillo Ábalos J; Tabernero S; Juliá B; Romero C; Cea-Calvo L; García-Vicuña R; Vanaclocha F
Gastroenterol Hepatol; 2014 Nov; 37(9):495-502. PubMed ID: 24717523
[TBL] [Abstract][Full Text] [Related]
16. Clinical manifestations of pyoderma gangrenosum associated with inflammatory bowel disease.
Menachem Y; Gotsman I
Isr Med Assoc J; 2004 Feb; 6(2):88-90. PubMed ID: 14986464
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.
Bernstein CN; Blanchard JF; Rawsthorne P; Yu N
Am J Gastroenterol; 2001 Apr; 96(4):1116-22. PubMed ID: 11316157
[TBL] [Abstract][Full Text] [Related]
18. Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity.
Dotson JL; Hyams JS; Markowitz J; LeLeiko NS; Mack DR; Evans JS; Pfefferkorn MD; Griffiths AM; Otley AR; Bousvaros A; Kugathasan S; Rosh JR; Keljo D; Carvalho RS; Tomer G; Mamula P; Kay MH; Kerzner B; Oliva-Hemker M; Langton CR; Crandall W
J Pediatr Gastroenterol Nutr; 2010 Aug; 51(2):140-5. PubMed ID: 20453677
[TBL] [Abstract][Full Text] [Related]
19. Dermatologic manifestations in inflammatory bowel disease in Tunisia.
Mebazaa A; Aounallah A; Naija N; Cheikh Rouhou R; Kallel L; El Euch D; Boubaker J; Mokni M; Filali A; Ben Osman A
Tunis Med; 2012 Mar; 90(3):252-7. PubMed ID: 22481199
[TBL] [Abstract][Full Text] [Related]
20. Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases.
Halling ML; Kjeldsen J; Knudsen T; Nielsen J; Hansen LK
World J Gastroenterol; 2017 Sep; 23(33):6137-6146. PubMed ID: 28970729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
